Paul W Armstrong Selected Research

Paul W Armstrong Research Topics

Disease

152	Myocardial Infarction 05/2022 - 01/2002
113	Acute Coronary Syndrome 11/2020 - 01/2002
110	ST Elevation Myocardial Infarction 05/2022 - 01/2003
107	Heart Failure 11/2022 - 01/2002
57	Hemorrhage 01/2020 - 01/2002
45	Stroke (Strokes) 01/2020 - 09/2003
27	Infarction (Infarctions) 01/2021 - 09/2003
20	Ischemia 03/2017 - 02/2002
16	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2002
16	Unstable Angina 01/2020 - 01/2002
15	Shock 05/2022 - 09/2003
12	Hypertension (High Blood Pressure) 01/2021 - 01/2002
11	Dyspnea (Shortness of Breath) 01/2018 - 02/2009
10	Type 2 Diabetes Mellitus (MODY) 01/2022 - 07/2015
10	Atrial Fibrillation 01/2021 - 08/2009
9	Inflammation (Inflammations) 05/2022 - 12/2004
9	Diabetes Mellitus 01/2021 - 11/2012
8	Thrombosis (Thrombus) 05/2022 - 05/2002
8	Coronary Disease (Coronary Heart Disease) 01/2019 - 05/2002
7	Chest Pain (Chest Pains) 01/2017 - 04/2003
6	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2020 - 12/2004
6	Body Weight (Weight, Body) 01/2018 - 04/2005
6	Cardiogenic Shock 08/2015 - 10/2005
6	Necrosis 07/2012 - 07/2003
5	Hypotension (Low Blood Pressure) 01/2022 - 11/2014
5	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 06/2002
5	Atherosclerotic Plaque (Atheroma) 01/2019 - 05/2002
5	Non-ST Elevated Myocardial Infarction 01/2018 - 05/2006
5	Myocardial Ischemia (Ischemic Heart Diseases) 01/2007 - 01/2002
4	Cardiomyopathies (Cardiomyopathy) 01/2022 - 02/2015
4	Renal Insufficiency (Renal Failure) 03/2016 - 03/2004
3	Anemia 11/2021 - 10/2004
3	Chronic Renal Insufficiency 01/2021 - 10/2016
3	Vascular Diseases (Vascular Disease) 11/2020 - 01/2016
3	Peripheral Arterial Disease 01/2020 - 10/2014
3	Transient Ischemic Attack 05/2017 - 02/2010
3	Acute Kidney Injury (Acute Renal Failure) 08/2016 - 10/2015

Drug/Important Bio-Agent (IBA)

45	Brain Natriuretic Peptide (Natrecor)FDA Link 06/2021 - 04/2006
41	pexelizumabIBA 11/2020 - 09/2003
37	Biomarkers (Surrogate Marker)IBA 05/2022 - 07/2003
33	Clopidogrel (Plavix)FDA Link 01/2020 - 01/2003
26	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 06/2002
22	vericiguatIBA 11/2022 - 01/2018
21	Prasugrel Hydrochloride FDA Link 01/2020 - 07/2010
19	vorapaxarIBA 12/2018 - 01/2012
19	Glycoproteins (Glycoprotein)IBA 01/2018 - 01/2002
19	Eptifibatide (Integrilin)FDA Link 04/2014 - 01/2002
18	Thrombin Receptors (Thrombin Receptor)IBA 01/2020 - 01/2012
17	CreatinineIBA 01/2020 - 12/2003
16	pro-brain natriuretic peptide (1-76)IBA 01/2020 - 04/2006
16	Enoxaparin (Lovenox)FDA LinkGeneric 07/2013 - 01/2003
15	Tenecteplase FDA Link 01/2020 - 08/2003
14	TroponinIBA 01/2020 - 04/2003
13	Creatine Kinase (Creatine Phosphokinase)IBA 01/2020 - 01/2002
13	MB Form Creatine KinaseIBA 10/2014 - 04/2003
13	Complement System Proteins (Complement)IBA 09/2013 - 09/2003
11	Sitagliptin Phosphate (Januvia)FDA Link 11/2020 - 07/2015
11	Heparin (Liquaemin)FDA LinkGeneric 01/2007 - 01/2003
10	Platelet Membrane GlycoproteinsIBA 10/2007 - 01/2002
8	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 09/2017 - 08/2002
8	Pharmaceutical PreparationsIBA 02/2016 - 01/2002
8	Streptokinase FDA Link 09/2013 - 07/2002
8	Abciximab (ReoPro)FDA Link 07/2010 - 11/2002
7	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2020 - 08/2002
6	paragonIBA 10/2007 - 02/2002
5	Soluble Guanylyl CyclaseIBA 11/2022 - 01/2018
5	DiureticsIBA 11/2022 - 12/2003
5	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2020 - 01/2016
5	darapladibIBA 01/2019 - 05/2014
5	Troponin IIBA 08/2018 - 04/2003
5	EnzymesIBA 05/2014 - 01/2002
5	Warfarin (Coumadin)FDA LinkGeneric 02/2010 - 04/2004
4	Hemoglobins (Hemoglobin)IBA 11/2021 - 02/2005
4	Peptide Hydrolases (Proteases)FDA Link 12/2018 - 03/2014
4	Fibrinolytic Agents (Antithrombotic Agents)IBA 06/2015 - 04/2004
4	Platelet Membrane Glycoprotein IIbIBA 05/2015 - 12/2006
3	Hormones (Hormone)IBA 06/2021 - 09/2010
3	CytokinesIBA 01/2021 - 02/2007
3	Interleukin-6 (Interleukin 6)IBA 01/2021 - 10/2005
3	omega-Chloroacetophenone (Mace)IBA 01/2020 - 08/2016
3	LDL CholesterolIBA 01/2020 - 08/2017
3	Hypoglycemic Agents (Hypoglycemics)IBA 12/2019 - 01/2016
3	HDL CholesterolIBA 01/2019 - 08/2014
3	TicagrelorIBA 01/2018 - 01/2012
3	Angiotensin Receptor AntagonistsIBA 09/2017 - 02/2006
3	C-Reactive ProteinIBA 07/2017 - 10/2005
3	NitrogenIBA 06/2017 - 01/2015
3	Urea (Carbamide)FDA LinkGeneric 06/2017 - 01/2015
3	SodiumIBA 06/2017 - 02/2015
3	PAR-1 ReceptorIBA 12/2015 - 07/2014
3	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 12/2015 - 04/2004

Therapy/Procedure

99	Percutaneous Coronary Intervention 05/2022 - 09/2003
97	Therapeutics 05/2022 - 01/2002
17	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2022 - 01/2002
16	Thrombolytic Therapy 01/2020 - 02/2002
16	Patient Readmission 12/2019 - 02/2009
6	Length of Stay 01/2018 - 02/2004
4	Secondary Prevention 12/2018 - 03/2003
4	Stents 05/2016 - 01/2009
3	Drug-Eluting Stents 09/2014 - 01/2009